<DOC>
	<DOCNO>NCT02205008</DOCNO>
	<brief_summary>Intraperitoneal chemotherapy adjuvant treatment modality design eradicate intraperitoneal free tumor cell source peritoneal carcinomatosis . Although reach unanimous consensus , favorable report outcome intraperitoneal chemotherapy publish . In study , review clinicopathological characteristic patient effect early postoperative intraperitoneal chemotherapy ( EPIC ) overall gastric cancer-specific survival pattern recurrence gastric cancer patient macroscopic serosal invasion . The aim study evaluate impact intraperitoneal chemotherapy overall disease free survival advance gastric cancer patient serosal invasion potentially curative surgery .</brief_summary>
	<brief_title>Intraperitoneal Chemotherapy Systemic Chemotherapy Versus Systemic Chemotherapy After Curative Resection Serosa-positive Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1. histologically proven adenocarcinoma stomach 2. preoperative suspicion serosal invasion radiological examination 3. candidate curative resection stomach D2 4. age 19 70 year old 5 . Eastern Cooperative Oncology Group Performance status :0 , 1 , 2 6. absolute neutrophil count≥1,500/microliter , hemoglobin≥9.0g/dL , platelet≥100,000/microliter 7. serum Creatinine &lt; 1.5mg/dL 8. total bilirubin &lt; 2 x upper normal limit , transaminase &lt; 3 x upper normal limit 9. patient without previous administration chemotherapeutic agent 10. patient agree sign informed consent form 1. malignancy stomach except adenocarcinoma 2. history hypersensitivity 5fluorouracil mitomycin 3. concomitant infectious disease 4. active hepatitis chronic liver disease 5. history psychotic disorder 6. patient disorders central nervous system 7. history malignancy within 5 year 8. history clinically significant heart disease ( congestive heart failure , symptomatic coronary artery disease , symptomatic arrhythmia , myocardial infarction ) 9. patient increase bleed tendency 10. pregnant lactate female patient 11. patient agree sign informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>advanced gastric cancer</keyword>
	<keyword>serosal invasion</keyword>
	<keyword>peritoneal recurrence</keyword>
	<keyword>intraperitoneal chemotherapy</keyword>
</DOC>